Cite
HARVARD Citation
Weiss, A. et al. (2022). Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial. Clinical and translational medicine. 12 (5), p. n/a. [Online].